uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Plegridy
Authorised
Human
Details
EMA number
EMEA/H/C/002827
ATC code
L03AB13
Authorisation
18 July 2014
Revision
30
EMA page
Therapeutic indication
Treatment of relapsing remitting multiple sclerosis in adult patients.
MeSH:
Multiple Sclerosis
Group:
Immunostimulants
Active substances
peginterferon beta-1a
Marketing Authorisation Holder
Biogen Netherlands B.V.
MAH
Timeline
Filter by authority:
EMA
Plegridy authorised
18 Jul 2014
authorised
regulatory
Plegridy | uMedical